Prevalence of complementary medicine use in a phase 1 clinical trials program

BACKGROUND: A key end point of early cancer clinical trials is the assessment of toxicities and their possible association with new experimental drugs. Therefore, the concurrent use of complementary and alternative medicine (CAM) in patients with advanced malignancies seen in a dedicated phase 1 cli...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer 2011-11, Vol.117 (22), p.5142-5150
Hauptverfasser:	Naing, Aung, Stephen, Saneese K., Frenkel, Moshe, Chandhasin, Chandtip, Hong, David S., Lei, Xiudong, Falchook, Gerald, Wheler, Jennifer J., Fu, Siqing, Kurzrock, Razelle
Format:	Artikel
Sprache:	eng
Schlagworte:	alternative medicine complementary medicine phase 1 clinical trials
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!